SEC Form 4 · accession 0001225208-19-002112
CLOROX CO /DE/ · CLX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew T Laszlo
Officer — SVP - Chief Customer Officer
Period of report
Feb 6, 2019
Accepted (ET)
Feb 8, 2019 · 5:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000021076
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 6, 2019 | M | 7,280 | $123.09 | A | 17,994 | D | |
| Common Stock | Feb 6, 2019 | M | 3,480 | $135.57 | A | 21,474 | D | |
| Common StockF1 | Feb 6, 2019 | S | 10,585 | $153.886 | D | 10,889 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $135.57 | Feb 6, 2019 | M | 3,480 | D | Sep 12, 2018 | Sep 12, 2027 | Common Stock | 3,480 | 10,440 | D |
| Stock Option (Right to Buy) | $123.09 | Feb 6, 2019 | M | 7,280 | D | Sep 13, 2017 | Sep 13, 2026 | Common Stock | 7,280 | 7,280 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $153.66 to $154.08. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.